R&D Center, YidoBio, Inc., 123 Beolmal-ro, Anyang-si, Gyeonggi-do, 14056, South Korea.
Department of Molecular Science and Technology, Ajou University, Suwon, 16499, South Korea.
Biochem Biophys Res Commun. 2021 May 7;552:164-169. doi: 10.1016/j.bbrc.2021.03.026. Epub 2021 Mar 19.
Human mesenchymal stem cells (MSCs) are known to have anti-inflammatory and immunomodulatory functions; thus, several MSC products have been applied as cell therapy in clinical trials worldwide. Recent studies have demonstrated that MSC spheroids have superior anti-inflammatory and immunomodulatory functions to a single cell suspension. Current methods to prepare MSC spheroids include hanging drop, concave microwell aggregation, spinner flask, and gravity circulation. However, all these methods have limitations such as low scalability, easy cell clumping, low viability, and irregular size distribution. Here, we present a nano-patterned culture plasticware named PAMcell™ 3D plate to overcome these limitations. Nano-sized silica particles (700 nm) coated with RGD peptide were arrayed into fusiform onto the PLGA film. This uniform array enabled the seeded MSCs to grow only on the silica particles, forming uniform-sized semi-spheroids within 48 h. These MSC spheroids have been shown to have enhanced stemness, anti-inflammatory, and immunomodulatory functions, as revealed by the increased expression of stem cell markers (Oct4, Sox2, and Nanog), anti-inflammatory (IL-10, TSG6, and IDO), and immunomodulatory molecules (HGF, VEGF, CXCR4) both at mRNA and protein expression levels. Furthermore, these MSC spheroids demonstrated an increased palliative effect on glycemic control in a multiple low-dose streptozotocin-induced diabetes model compared with the same number of MSC single cell suspensions. Taken together, this study presents a new method to produce uniform-sized MSC spheroids with enhanced anti-inflammatory and immunomodulatory functions in vitro and in vivo.
人骨髓间充质干细胞 (MSCs) 具有抗炎和免疫调节功能;因此,几种 MSC 产品已作为细胞疗法在全球临床试验中应用。最近的研究表明,MSC 球体具有比单细胞悬浮液更好的抗炎和免疫调节功能。目前制备 MSC 球体的方法包括悬滴、凹微井聚集、搅拌瓶和重力循环。然而,所有这些方法都存在局限性,例如可扩展性低、容易细胞聚集、存活率低和尺寸分布不规则。在这里,我们提出了一种名为 PAMcell™ 3D 板的纳米图案化培养塑料,以克服这些限制。涂有 RGD 肽的纳米级二氧化硅颗粒(700nm)被排列成梭形到 PLGA 膜上。这种均匀的排列使接种的 MSC 只能在二氧化硅颗粒上生长,在 48 小时内形成均匀大小的半球体。这些 MSC 球体已被证明具有增强的干性、抗炎和免疫调节功能,这表现在干细胞标志物(Oct4、Sox2 和 Nanog)、抗炎(IL-10、TSG6 和 IDO)和免疫调节分子(HGF、VEGF、CXCR4)的表达水平上。此外,与相同数量的 MSC 单细胞悬浮液相比,这些 MSC 球体在多次低剂量链脲佐菌素诱导的糖尿病模型中对血糖控制的姑息作用增加。总之,这项研究提出了一种新的方法,可在体外和体内产生具有增强的抗炎和免疫调节功能的均匀大小的 MSC 球体。